Veterinary Medicine

JMAR Technologies Raises Awareness of BioSentry -- A High Tech Counter to Bioterrorism

JMAR Technologies, Inc. (OTCBB: JMAR), San Diego, CA, a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced a media awareness initiative for JMAR's award-winning, laser-based BioSentry®, which is the only commercialized, EPA tested, online system for real-time detection of pathogens in water.

San Diego, CA (PRWEB) January 13, 2009 -- U.S. water distribution systems are potential terrorist targets due to the critical need for clean water in all sectors of society. A terrorist attack that contaminates a public or private municipal water system will cause devastating economic and public health consequences. With the most recent warnings of bio-attack threats, JMAR (http://www.jmar.com) is alerting the public, our government officials, and the incoming Obama Administration about the benefits of using BioSentry® (http://www.jmar.com/2004/prod_BioSentry.shtml). As a high tech counter to bioterrorism, BioSentry® can help prevent economic and political disruption, widespread sickness, and fatalities from contaminated water that goes undetected until it is too late.

As part of this initiative, JMAR representatives are attending a conference in Washington, D.C., which specifically addresses "Shaping the Obama Administration's Counterterrorism Strategy," at the CATO Institute on January 12-13, 2009. Later this week, on January 15, 2009, CNBC will be airing a prime-time BioSentry® video news release (http://www.jmar.com/BioSentry_bioterrorism.shtml). The video is expected to reach 4,000,000 viewers, and will also be distributed to 190 cable stations nationwide through the Independent News Network.

"I have the utmost confidence that this initiative will be successful in highlighting the nature of the threat and the importance of taking action now to protect the public from a bioterrorist attack, " said JMAR's Chief Executive Officer, C. Neil Beer, Ph.D. "We need to secure our water supplies - BioSentry® provides the continuous monitoring necessary for protection against contamination, intentional or otherwise."

Frost & Sullivan recognized BioSentry® as the leading innovative approach to water quality monitoring and selected JMAR for their 2008 Biological Detection Product of the Year Award (http://www.frost.com/prod/servlet/press-release.pag?docid=145709774&ctxixpLink=FcmCtx1&ctxixpLabel=FcmCtx2).

To be added to JMAR Technologies' investor lists, please contact Haris Tajyar at 818-382-9702.

About JMAR:

JMAR Technologies, Inc. (OTCBB: JMAR) is a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials. Coupled with its established expertise in building advanced laser systems, JMAR provides solutions for a broad range of military, industrial and commercial applications. The Company draws on more than twenty years of experience and twenty-nine patents and patents pending in photonics, laser and detection technologies to develop products and solutions that address some of the world's most pressing issues such as water quality, hazard detection and homeland security. JMAR's vision is to continue to develop innovative technologies and products that support the advancement of global health, safety, and security initiatives. For further information on JMAR Technologies, please visit JMAR Technologies Website (http://www.jmar.com).

About CATO:

The Cato Institute was founded in 1977 by Edward H. Crane. It is a non-profit public policy research foundation headquartered in Washington, D.C. Its mission is to increase the understanding of public policies based on the principles of limited government, free markets, individual liberty and speech.

Forward Looking Statements: This news release contains certain "forward-looking statements." Forward-looking statements are based on current expectations and assumptions and are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, and many of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a number of factors, including the uncertainty of acceptance in the market for our products and technologies or the acceptance of our customers' products or technologies which incorporate our products and technologies, the failure of our technology to perform as predicted, competition from alternative technologies, uncertainties as to the size of the markets, cost and margins for JMAR's products, current or future government regulations affecting the use of JMAR's products, the lack of availability of critical components, the degree of protection from future patents, other risks associated with the development or acquisition of new products or technologies and those risks detailed in the Company's Form 10-K for the year ended December 31, 2007 filed with the SEC. Given these risks and uncertainties, investors are cautioned not to place undue reliance on such forward-looking statements and no assurances can be given that such statements will be achieved. JMAR Technologies, Inc. does not assume any duty to publicly update or revise the material contained herein.

# #

DoD Leader to Address Presidential Biometrics Security Directive at NDIA Conference

General Victor E. Renuart, Jr., will address attendees regarding the implementation of Homeland Security Presidential Directive/HSPD – 24 at the 2009 Biometrics Conference www.ndia.org/meetings/9860 on January 27-28, 2009 at the Sheraton National Hotel in Arlington, VA.

Arlington, VA (Vocus) January 13, 2009 – General Victor E. Renuart, Jr., Commander, North American Aerospace Defense Command and U.S. Northern Command, Peterson Air Force Base, CO, will address attendees regarding the implementation of Homeland Security Presidential Directive/HSPD – 24 at the 2009 Biometrics Conference (http://www.ndia.org/meetings/9860) January 27-28, 2009 at the Sheraton National Hotel in Arlington, VA.

General Renuart will discuss his plan to bolster Homeland Security identification and screening efficacy through the use of biometrics in response to Homeland Security Presidential Directive/HSPD – 24. He will also touch on how the biometrics industry, the Department of Defense and Homeland Security, The Attorney General working with the Secretaries of State, the Director of National Intelligence and the Director of the Office of Science and Technology will join forces to develop an Action Plan for implementing HSPD-24 by June 2009.

The purpose of Homeland Security Presidential Directive/HSPD – 24 is to establish a framework to ensure that Federal executive departments and agencies use mutually compatible methods and procedures in the collection, storage, use, analysis, and sharing of biometric and associated biographic and contextual information of individuals in a lawful and appropriate manner, while respecting their information privacy and other legal rights under United States law.

“Cross agency compatible Biometric technologies will allow us to screen and identify possible threats with a higher level of accuracy and efficiency than we’ve ever experienced before.” said Martha Karlavic, Chair person of the NDIA Industrial Committee on Biometrics and the Vice President of Security & Identity Management for SAIC. “We’ve designed an agenda for this conference to address the challenges in identifying the enabling technologies that address the current, and more importantly, future demands for a screening, analysis and information sharing pipeline that will keep us one step ahead of an ever evolving threat to national security. We’ve extremely excited about General Victor E. Renuart, Jr.’s involvement in this year’s conference as well as the cast of speakers that we’ve been able to assemble to address this pressing issue for industry and government.”

HSPD-24, “Biometrics for Identification and Screening to Enhance National Security,” June 2008, creates the framework for a biometric network, to defeat a terrorist network by “sharing of biometric and associated biographical and contextual information.” It calls for a “layered approach to identification and screening of individuals, as no single mechanism is sufficient” across multiple sovereign jurisdictions of Federal, States, local and tribal authorities. The Federal Government has responsibility for 115 airports, 14 seaports, 150 land ports, 220 consulates and two sea borders and the two land borders with numerous waterways. HSPD-24 is challenged by multiple jurisdictions, different technologies and policies.

NDIA’s 2009 Biometric Conference has been designed to be an open forum for identifying and discussing practical approaches to the challenges of successfully implementing HSPD-24.

The NDIA conference will examine a broad spectrum of issues ranging from:

•    Policy development

•    Existing and planned U.S. Government programs

•    Examples of commercial application of biometrics to address mission critical business goals

•    Enabling technologies

•    Initiatives within the international community

•    Challenges to achieving true interoperability and information sharing

The conference’s goal is to develop a mutual understanding and cardinal direction for possible solutions wherein jurisdiction gaps are closed, technologies are interoperable and policies are cohesive.

To find out more information about the 2009 Biometrics Conference or to register for this event go to www.ndia.org/meetings/9860

About NDIA:

The National Defense Industrial Association (http://www.ndia.org) is America’s leading defense industry association promoting national security through communication and knowledge-exchange between industry and the government. NDIA has nearly 1,500 corporate members and more than 64,300 individual members from the defense/security industry, the government and military. NDIA supports its mission through technical symposia, expositions, government advocacy, regional chapters, technical divisions, affiliate associations and its award winning magazine, National DEFENSE.

##

TodayMD Renews Race Sponsorship With Alegra Motorsports For A Third Year

Nation's leading medical internet marketing company to serve as an affiliate sponsor of Alegra Motorsports during the 2009 GrandAm Rolex Sports Car Series® season

Miami, FL (PRWEB) January 13, 2009 -- TodayMD (http://www.TodayMD.com), the nations leading medical internet marketing company (http://www.TodayMD.com), announced today that it will continue its partnership with Alegra Motorsports one of the sponsors of the No. 22 car driven by team owner and veteran driver Carlos De Quesada along with his co-drivers, during the 2009 GRAND AM Rolex Sports Car Series season.

"With so many teams merging or taking on investors, Carlos De Quesada represents a one-of-a-kind driver and owner in GRAND AM's top racing series. His tenacity and commitment shows he has the competitive spirit, that our customers value and respect," said Michael DiCicco, Chief Marketing Officer, TodayMD. "We are proud to continue our support of Carlos and his race team as they demonstrate true character and achieve success on the track."

TodayMD will be one of the sponsors for the entire Rolex Sports Car Series races in 2009, along with long time supporter, Gatorade, as well as a new primary sponsor, Strategic Air. The deal marks the company's third year of partnership with Alegra Motorsports, a relationship that began in 2005.

"We're thrilled to welcome back TodayMD to our team," said de Quesada. "TodayMD is an excellent company, and they're a perfect fit for our fans' demographics. With TodayMD's continued support for the No. 22 team, we can focus on improving our race program and build our way towards a successful 2009 season."

The marketing partnership will kick off 2009 at the most prestigious endurance sports car race in North America, the Rolex 24 at Daytona International Speedway in Daytona Beach, Fla. on Jan. 24-25.

Alegra Motorsports won this event's GT class in 2007. This year it is fielding a Riley BMW Daytona Prototype, No. 22.

At the Rolex 24 the car will be driven by team owner Carlos de Quesada of Coral Gables, Fla.; Scotland's Ryan Dalziel of Orlando, Fla.; Chapman Ducote of Miami Beach, Fla.; Jean-Francois Dumoulin of Trois-Rivieres, Quebec; and the Czech Republic's Tomas Enge of Monte Carlo. It will be driven by Dalziel, de Quesada and Ducote for the subsequent shorter events in the 12-race season. TodayMD will utilize its sponsorship to reach race fans both on and off the track through a variety of racing related promotions. TodayMD, is an innovator in online marketing technology and services for medical and dental practices, as well as other health related organizations, and also has a strategic relationship with Google.

TodayMD is an authorized reseller of Google AdWords. AdWords is an online advertising program designed to help businesses of all sizes use the Web to find new customers by delivering relevant ads when users search for specific products and services. Expanding their search engine marketing (SEM) program to incorporate the Google AdWords offering enables TodayMD to deliver strong search engine marketing strategies to their medical and dental clients while maximizing their marketing dollars. In addition to this service, TodayMD also offers a complete suite of internet marketing solutions including web site development, and search engine optimization, just to name a few.

Created in 1996, Alegra Motorsports has become a name synonymous with sportscar racing. It is comprised of those dedicated to racing and its sole purpose is the participation in sportscar events in the United States and Internationally. We have participated in many sportscar events ranging from auto-club events to the professional arena. This includes Historic Sportscar Racing, Porsche Club of America, Porsche-BMW Owners Club, SCCA, Grand American Road Racing Association (24 Hours of Daytona), and the American Lemans Series.

For additional information on the TodayMD services, contact Michael DiCicco at 866-923-9263 or visit www.TodayMD.com

About Alegra Motorsports

Based in Miami, FL. and owned by De Quesada, will enter another season of competition in 2009 in the GRAND AM Rolex Sports Car Series, and will continue to operate successful racing programs.

About TodayMD:

TodayMD is a medical and health care industry pioneer and a leader in helping small, medium, and large-sized medical practices and health care organizations attract local customers via search engine advertising (http://www.TodayMD.com), website development, and other marketing solutions.

TodayMD's local online advertising platforms provide medical practices with simple and affordable ways to get more phone calls -and new patients.

Our integrated services approach is changing the way medical practices advertise to local markets both offline and online.

TodayMD is a privately held company headquartered in Miami, FL with presence throughout the USA and abroad.

Google and AdWords are trademarks of Google Inc

Contact:

TodayMD

Michael Dicicco

305-629-3831

##

Alter-G Secures $8 Million in Series B Financing from Versant Ventures

Versant Ventures Managing Director, Ross Jaffe, M.D. Joins Board Of Directors

Menlo Park, Calif. (Vocus) January 13, 2009 -- Alter-G (www.alter-g.com), a privately held medical device company based in Menlo Park California, has secured an $8 million round of series B funding from Versant Ventures. The proceeds will be used to continue to accelerate the company's growth. Ross A. Jaffe, MD, Managing Director at Versant Ventures (www.versantventures.com), will join Alter-G's board of directors.

"This capital allows us to pioneer a market using proprietary technologies to help people recover from disability and sustain a healthy and active life", said Lars Barfod, CEO of Alter-G Inc. "I am also delighted to welcome Ross Jaffe on our board. Ross brings a tremendous amount of experience and understanding of our market to the board. We are excited about being part of Versant's significant portfolio of investments in the medical device space".

The company will use the proceeds in four key areas that will help to further accelerate its growth: expand sales and services globally, increase rate of clinical research, add to product development capabilities and build additional intellectual property.

"We are impressed by the team, the positive customer feedback and the proprietary technology's potential in a market where the demographics show rapid growth and where the treatment alternatives remain limited", said Ross A. Jaffe, MD, Managing Director of Versant Ventures. "We believe Alter-G's products have the potential to improve outcomes in significant areas of human disability, as well as offering a valuable new approach to sports training, fitness, and geriatric wellness".

Versant Ventures will join the two founding investor groups, Frog & Peach Investors and Red Planet Capital, as the key shareholders of Alter-G Inc.

About Alter-G:

Alter-G, Inc. is the only company to offer FDA-cleared rehabilitation and therapy equipment built on revolutionary, anti-gravity technologies originally developed at NASA. Tested by Nike's Oregon Research Project for distance runners, its patented equipment is used to provide unweighted physical therapy treatments at America's most respected major medical centers, and is used in leading professional, collegiate, and individual sports and fitness programs. Located in Silicon Valley, Alter-G's innovatively engineered products, including its flagship G-Trainer anti-gravity treadmill, are sold in North America, Europe, and Asia. Learn more at www.alter-g.com.

About Versant Ventures:

Versant Ventures invests in seed, early-stage and selective later stage companies in medical devices, biotechnology or pharmaceuticals. As a leading healthcare venture firm, Versant makes investments where there is the potential for dramatic clinical improvement across large patient populations. Founded in 1999, Versant has invested in 95 companies, including public companies Genomic Health (GHDX) and Insulet (PODD), and companies that have been acquired such as eyeonics, Intralase, Lipsonix, NovaCardia, Pharmion, Reliant, St. Francis Medical Technologies, and Syrrrx. Versant has $1.6 Billion in capital under management in four funds. The firm's primary offices are in Menlo Park and Newport Beach, California. For more information, visit www.versantventures.com.

##

More than Just a Box of Chocolates

Ready to do more this Valentine's Day with your love? Get some pointers on how to comfort and support a loved one facing a health challenge from CarePages.

Chicago (Vocus) January 13, 2009 -- Does love truly conquer all? Millions of patients facing health challenges whom have found support and compassion through online communities such as CarePages.com (http://www.carepages.com/) believe it does. To them, love is more than a dozen roses or candlelit dinner on Valentine's Day - it's a matter of healing, strength and defying the odds for survival.

Just ask Lisa, who was diagnosed with Stage IV non-smokers lung cancer, which had spread to her brain, in April 2006. She credits her family's love and a community of more than 2,600 visitors extending from California to New England for fueling her fierce determination to fight the cancer. Lisa will soon embark on yet another line of treatment to battle the tumors, and although she and her husband are still weighing their options, they know they'll have all the support they could imagine.

"It is an incredible feeling to realize there are a number of different groups of people who are basically waiting in the wings for us to call for help when we're ready. We are thankful every day to live through repeated examples of how good people really are." (CarePage: LisasRoadtoRecovery)

Or ask Barbie, whose daughter was diagnosed with leukemia when she was just three, who also acknowledges her CarePages community for providing the much-needed support while facing her daughter's many spinal taps, blood transfusions and chemo treatments. With family far away, Barbie found strength to care for her young daughter and help her beat the disease to live a fun and fulfilled life.

"CarePages is my therapy. I get up every morning and I open my CarePage. And I go to bed at night and I read my CarePage… I don't know what we would do without this CarePage community." (CarePage: OurLittlePrincess)

A survey of nearly 900 caregivers and visitors to CarePages.com, whose mission is to ensure that no one faces a health challenge alone, found that 99 percent believed emotional support can have a positive effect on the healing process. With stories like Lisa's and Barbie's, it's hard not to believe that the Internet is transforming health care. Proving the true power of love, online health sites and social networks are helping doctors and hospitals treat the whole person - a patient's mind and spirit along with the illness. A recent white paper (http://cms.carepages.com/CarePages/en/Press/whitepapers.html) released by CarePages.com explores the implications of these trends and recent research.

"It takes more than medicine to heal. We must meet our most elemental needs for personal connections and community, too, and the Internet is rapidly evolving to meet those needs," says Dr. Sharon Langshur (http://cms.carepages.com/CarePages/en/Press/bios.html), co-founder of CarePages (http://www.carepages.com/). "I'm continually touched by the powerful and inspirational stories of our members who find strength, healing and courage through their online connections."

In 2008, CarePages commissioned a Nielsen Online study of health sites, and more than 10 percent of discussions were dedicated to messages of appreciation, gratitude and the positive impact of receiving love and emotional support. The patients' Web sites, blogs and discussion forums (http://www.carepages.com/forums/spirituality) on CarePages are no exception.

Ready to do more this Valentine's Day with your love? Get some pointers on how to comfort and support a loved one facing a health challenge from CarePages (http://cms.carepages.com/CarePages/en/ArticlesTips/HelpfulTips/BetterYou/comfort_sick_friend.html). Or, hear about the power of CarePages first hand from members like Barbie and Lisa by viewing our latest video (http://cms.carepages.com/CarePages/en/Press/video.html).

For more information, please visit our online press room (http://cms.carepages.com/CarePages/en/Press/index.html) or contact Emily Shirden at 312.423.4933.

About CarePages:

CarePages is an online community of millions of people coming together to share the challenges, hopes and triumphs of anyone facing a life-changing health event. Through personalized websites, members can relate their stories, post photos and update friends and family instantly. In turn, people who care send messages of love and encouragement. CarePages.com also offers a variety of resources and support tools for living a more compassionate life.

Private-labeled CarePages websites are also offered by over 700 U.S. and Canadian healthcare facilities. CarePages has a simple, singular mission: to ensure that no one faces a health challenge alone. For more information, please visit www.carepages.com.

##